Intestinal dysbiosis fuels liver disease progression via NLRP3 in the Mdr2-/- mouse model of primary sclerosing cholangitis

被引：0

作者：

Liao, Lijun ^{[1
,2
]}

Schneider, Kai Markus ^{[1
]}

Eric, Galvez ^{[3
]}

Frissen, Mick ^{[1
]}

Marschall, Hanns-Ulrich ^{[4
]}

Sun, Huan ^{[1
]}

Hatting, Maximilian ^{[1
]}

Wahlstroem, Annika ^{[4
]}

Haybaeck, Johannes ^{[5
,6
]}

Puchas, Philip ^{[6
]}

Mohs, Antje ^{[1
]}

Jin, Peng ^{[1
]}

Bergheim, Ina ^{[7
]}

Nier, Anika ^{[7
]}

Hennings, Julia ^{[1
]}

Reissing, Johanna ^{[1
]}

Wolfgang, Zimmermann Henning ^{[1
]}

Longerich, Thomas ^{[8
]}

Strowig, Till ^{[3
]}

Liedtke, Christian ^{[1
]}

Cubero, Francisco Javier ^{[1
,9
]}

Trautwein, Christian ^{[1
]}

机构：

[1] Univ Hosp RWTH Aachen, Dept Internal Med 3, Aachen, Germany

[2] Tongji Univ, Shanghai East Hosp, Dept Anesthesiol & Pain Management, Shanghai, Peoples R China

[3] Helmholtz Ctr Infect Res GmbH, Braunschweig, Germany

[4] Wallenberg Inst & Labs, Dept Mol & Clin Med, Gothenburg, Sweden

[5] Univ Magdeburg, Dept Pathol, Magdeburg, Germany

[6] Med Univ Graz, Dept Pathol, Graz, Austria

[7] Univ Vienna, Mol Nutr Sci Div, Dept Nutr Sci, Vienna, Austria

[8] Heidelberg Univ Hosp, Liver Canc Ctr Heidelberg, Heidelberg, Germany

[9] Univ Complutense Madrid, Sch Med, Dept Immunol, Madrid, Spain

来源：

JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期

关键词：

D O I：

10.1016/S0618-8278(19)30177-X

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

PS-159

引用

页码：E100 / E100

页数：1

共 50 条

[31] ENDTP1/CD39 deficiency aggravates liver injury and fibrosis in sclerosing cholangitis model in Mdr2-/- mice
Peng, Zhen-Wei
Ikenaga, Naoki
Liu, Susan B.
Robson, Simon C.
Popov, Yury
HEPATOLOGY, 2014, 60 : 402A - 402A
[32] MANIPULATION OF THE MIR-16/FGF-1 AXIS REDUCES PROFIBROTIC, PROLIFERATIVE, AND INFLAMMATORY PHENOTYPES IN THE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
O'Brien, April
White, Tori
Kyritsi, Konstantina
Francis, Heather L.
Zhou, Tianhao
Chakraborty, Sanjukta
Meng, Fanyin
Alpini, Gianfranco
Glaser, Shannon S.
HEPATOLOGY, 2020, 72 : 309A - 310A
[33] LONG-TERM ADMINISTRATION OF THE SECRETIN RECEPTOR ANTAGONIST, SCT 5-27, INHIBITS BILIARY SENESCENCE AND LIVER FIBROSIS OF PRIMARY SCLEROSING CHOLANGITIS (PSC) IN THE MDR2-/- MOUSE MODEL.
Wu, Nan
Kennedy, Lindsey
Zhou, Tianhao
Kyritsi, Konstantina
Chen, Lixian
Ceci, Ludovica
Grumbles, Kassidy
Francis, Heather L.
Meadows, Vik
Meng, Fanyin
Ekser, Burcin
O'Brien, April
Rivosecchi-Fulton, Jessica
Onori, Paolo
Gaudio, Eugenio
White, Tori
Glaser, Shannon S.
Alpini, Gianfranco
GASTROENTEROLOGY, 2020, 158 (06) : S1277 - S1277
[34] INHIBITION OF TRANSFORMING GROWTH FACTOR BETA 1 (TGFβ1) BY VIVO-MORPHOLINO (VM) AMELIORATES CHOLESTASIS IN THE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
Chen, Lixian
Zhou, Tianhao
Kundu, Debjyoti
Meadows, Vik
Kennedy, Lindsey
Kyritsi, Konstantina
Wu, Nan
Meyer, Alison A.
Owen, Travis M.
Alpini, Gianfranco
Francis, Heather L.
GASTROENTEROLOGY, 2022, 162 (07) : S1216 - S1216
[35] Role of adaptive hepatobiliary transporter expression and regulation of bile acid synthetic enzymes in MDR2-/- mice: A model for chronic cholestatic liver disease due to sclerosing cholangitis
Wagner, M
Fickert, P
Zollner, G
Fuchsbichler, A
Gumhold, J
Silbert, D
Zatloukal, K
Gu, GL
Marschall, HU
Denk, H
Trauner, M
JOURNAL OF HEPATOLOGY, 2004, 40 : 163 - 163
[36] Administration of Serotonin Receptor 2A/2B/2C Antagonists Decreases Ductular Reaction and Hepatic Fibrosis in the Mdr2-/- Mouse Model of Primary Sclerosing Cholangitis (PSC).
Kyritsi, Konstantina
O'Brien, April
White, Tori
Chen, Lixian
Meng, Fanyin
Venter, Juliet
Wu, Nan
Zhou, Tianhao
Alpini, Gianfranco
Glaser, Shannon S.
HEPATOLOGY, 2018, 68 : 131A - 131A
[37] FORKHEAD BOX PROTEIN A2 (FOXA2) REGULATES LIVER PHENOTYPES IN THE MULTI-DRUG RESISTANT 2 KNOCKOUT (MDR2-/-) MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC) AND HUMAN CHOLANGIOCYTES FROM PSC LIVER EXPLANTS
Wu, Nan
Zhou, Tianhao
Kennedy, Lindsey
Carpino, Guido
Onori, Paolo
Ceci, Ludovica
Kyritsi, Konstantina
Marakovits, Corinn N.
Gaudio, Eugenio
Ekser, Burcin
Barapula, Nipuni Punsara
Franchitto, Antonio
Chen, Lixian
Francis, Heather L.
Alpini, Gianfranco
Glaser, Shannon S.
GASTROENTEROLOGY, 2023, 164 (06) : S1356 - S1356
[38] Melatonin Therapy Reduces Biliary Proliferation and Hepatic Fibrosis in the Mdr2-/- Mouse Model of Primary Sclerosing Cholangitis (PSC) By Decreased Expression of miR-200b and Angiogenic Factors
Wu, Nan
Meng, Fanyin
Venter, Julie
Francis, Heather L.
Standeford, Holly
DeMorrow, Sharon
Franchitto, Antonio
Onori, Paolo
Gaudio, Eugenio
Alpini, Gianfranco
Glaser, Shannon
GASTROENTEROLOGY, 2016, 150 (04) : S1046 - S1046
[39] PROLONGED ADMINISTRATION OF MELATONIN TO THE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSIS CHOLANGITIS (PSC) DECREASES BILIARY SENESCENCE AND LIVER FIBROSIS THROUGH RESTORATION OF THE CIRCADIAN RHYTHM.
Ceci, Ludovica
Wu, Nan
Francis, Heather L.
Chen, Lixian
Zhou, Tianhao
Kennedy, Lindsey
Kyritsi, Konstantina
Grumbles, Kassidy
Rivosecchi-Fulton, Jessica
Meadows, Vik
Wu, Chaodong
Kundu, Debjyoti
Meng, Fanyin
Franchitto, Antonio
Gaudio, Eugenio
Onori, Paolo
Mancinelli, Romina
Alpini, Gianfranco
Glaser, Shannon S.
GASTROENTEROLOGY, 2020, 158 (06) : S1309 - S1309
[40] CCL24 modulates fibrosis development in primary sclerosing cholangitis: correlation of human serum CCL24 levels with fibrosis markers and data from the Mdr2-/- mouse model
Barashi, Neta
Segal, Michal
Aharon, Arnon
Katav, Avi
Mor, Adi
Mishalian, Inbal
Olam, Devorah
Peled, Amnon
Saffioti, Francesca
Thorburn, Douglas
JOURNAL OF HEPATOLOGY, 2020, 73 : S486 - S486

← 1 2 3 4 5 →